Chemify, a company specializing in molecular design, discovery, and chemical manufacturing technology, has announced $43 million in funding, including a Series A led by Triatomic Capital. The funding round also includes participation from new investors such as Hong-Kong based Horizon Ventures, US-based Rocketship Ventures, Possible Ventures, Alix Ventures, Scotland-based Eos, and the UK Government Innovation Accelerators program. Existing investor BlueYard Capital also participated in the round.
Chemify, founded in 2019 by CEO Lee Cronin with backing from David Cleevely, is based on decades of chemistry research, robotics, AI, and conceptual advancements from Cronin’s Digital Chemistry Laboratory at the University of Glasgow in Scotland.
The company aims to digitize chemistry and use artificial intelligence to explore ‘chemical space,’ accessing and creating trillions of possible combinations of natural elements. This approach can potentially reduce the time and cost required for discovering new molecules, benefiting industries such as pharmaceuticals, biotechnology, materials science, and green energy.
Chemify’s vision is to build the infrastructure to digitize chemistry and enable the execution of chemical code for drug discovery, chemical synthesis, and materials discovery. By creating a digital chemical future, Chemify aims to increase the speed of innovation and generate new chemical technologies for the benefit of humanity.
The company plans to work closely with partners in drug discovery, advanced materials, industrial chemicals, and other fields to provide access to its platform and address complex chemical design and manufacturing challenges.
